NEURON23
Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease. The company was founded in 2018 and is based in San Francisco, California, United States.
NEURON23
Industry:
Health Care Medical Pharmaceutical
Founded:
2018-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.neuron23.com
Total Employee:
11+
Status:
Active
Total Funding:
213.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Advisors List
Current Employees Featured
Founder
Investors List
Surveyor Capital
Surveyor Capital investment in Series C - Neuron23
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series C - Neuron23
Acorn Bioventures
Acorn Bioventures investment in Series C - Neuron23
Westlake Village BioPartners
Westlake Village BioPartners investment in Series C - Neuron23
SoftBank Vision Fund
SoftBank Vision Fund investment in Series C - Neuron23
Perceptive Advisors
Perceptive Advisors investment in Series C - Neuron23
Redmile Group
Redmile Group investment in Series C - Neuron23
HBM Partners
HBM Partners investment in Series C - Neuron23
Kleiner Perkins
Kleiner Perkins investment in Series C - Neuron23
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series C - Neuron23
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-12 | Neuron23 Appoints Sam Jackson, M.D., MBA, as Chief Medical Officer |
Official Site Inspections
http://www.neuron23.com Semrush global rank: 5.5 M Semrush visits lastest month: 1.55 K
- Host name: 70.35.200.219
- IP address: 70.35.200.219
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ... 